FACT: an open-label randomized phase III study of fulvestrant and anastrozole in combination compared with anastrozole alone as first-line therapy for patients with receptor-positive postmenopausal breast cancer
| Image |  |
|---|---|
| Description | scientific article published on 27 February 2012 |
| Author/s |
author: Justin Lindemann |
| Publication date | February 27, 2012 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |